179 related articles for article (PubMed ID: 14982812)
1. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
Stern JB; Girard P; Caliandro R
Antimicrob Agents Chemother; 2004 Mar; 48(3):1065. PubMed ID: 14982812
[No Abstract] [Full Text] [Related]
2. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C
Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935
[TBL] [Abstract][Full Text] [Related]
3. Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
de Sévaux RG; Kullberg BJ; Verweij PE; van de Nes JA; Meis JF; van der Meer JW
Clin Infect Dis; 1998 Apr; 26(4):996-7. PubMed ID: 9564492
[No Abstract] [Full Text] [Related]
4. Voriconazole. UK 109496.
Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
[No Abstract] [Full Text] [Related]
5. Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis.
Mehta H; Mehta HB; Garg P; Kodial H
Indian J Ophthalmol; 2008; 56(3):243-5. PubMed ID: 18417831
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
MacCallum DM; Whyte JA; Odds FC
Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
[TBL] [Abstract][Full Text] [Related]
7. A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
Matsuda T; Koreeda Y; Mataki H; Taira T; Noma S; Higashimoto I
Intern Med; 2010; 49(12):1163-9. PubMed ID: 20558936
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
Seyedmousavi S; Mouton JW; Verweij PE; Brüggemann RJ
Expert Rev Anti Infect Ther; 2013 Sep; 11(9):931-41. PubMed ID: 24053274
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole concentrations in synovial fluid and bone tissues.
Denes E; Boumediene A; Durox H; Oksman A; Saint-Marcoux F; Darde ML; Gaulier JM
J Antimicrob Chemother; 2007 Apr; 59(4):818-9. PubMed ID: 17329266
[No Abstract] [Full Text] [Related]
10. The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.
Stewart RM; Quah SA; Neal TJ; Kaye SB
Br J Ophthalmol; 2007 Aug; 91(8):1094-6. PubMed ID: 17638830
[No Abstract] [Full Text] [Related]
11. Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
Boyd NK; Zoellner CL; Swancutt MA; Bhavan KP
Antimicrob Agents Chemother; 2012 Nov; 56(11):6001-2. PubMed ID: 22890768
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Oct; 44(10):2865-8. PubMed ID: 10991875
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
[TBL] [Abstract][Full Text] [Related]
14. Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.
Poupelin JC; Philit F; Richard JC; Badet M; Lemasson S; Bayle F; Guérin C
Intensive Care Med; 2006 Jun; 32(6):939-40. PubMed ID: 16532330
[No Abstract] [Full Text] [Related]
15. Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
Dannaoui E; Garcia-Hermoso D; Naccache JM; Meneau I; Sanglard D; Bouges-Michel C; Valeyre D; Lortholary O
J Med Microbiol; 2006 Oct; 55(Pt 10):1457-1459. PubMed ID: 17005798
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Chandrasekar PH; Cutright J; Manavathu E
J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.
Kim JE; Perkins SL; Harris GJ
Arch Ophthalmol; 2003 May; 121(5):735-7. PubMed ID: 12742860
[No Abstract] [Full Text] [Related]
18. Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
George D; Miniter P; Andriole VT
Antimicrob Agents Chemother; 1996 Jan; 40(1):86-91. PubMed ID: 8787885
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus fumigatus Empyema in Heart Transplant Recipients.
De Vega Sánchez B; Varela Falcón LH; Vielba Dueñas D; Sayago Silva I; De la Fuente Galán L; Disdier Vicente C
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):402-403. PubMed ID: 28473264
[No Abstract] [Full Text] [Related]
20. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
